Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Medikaloka Hermina Tbk.
HEAL
Sector: Healthcare
Industry: Healthcare Providers
Sub Sector: Healthcare Equipment & Providers
Sub Industry: Healthcare Providers
HEAL
09:01
685
β–² +5 (+0.74%)
High 0
Low 0
Open
Prev 680
TVol 37.200
Highlight Keuangan (2026 Q2) (In Rp)
EPS
25
ROE
7,01%
ROA
3,22%
Book Value
359
Net Income
193,18 M
Total Sales
3,61 T
Total Assets
11,99 T
DER
0.89x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
21,57%
Corporate · Lokal
Corporate · Lokal
Individual · Lokal
Individual · Lokal
Individual · Lokal
Individual · Lokal
Private Equity · Asing
Private Equity · Asing
Private Equity · Lokal
Individual · Lokal
Individual · Lokal
Individual · Lokal
International Organization · Asing
Individual · Lokal
Individual · Lokal
Individual · Lokal
Individual · Lokal
Individual · Lokal
Corporate · Asing
Individual · Lokal
Individual · Lokal
Individual · Lokal
Tentang Perusahaan
PT Medikaloka Hermina Tbk (β€œthe Company”) was established based on Notarial Deed of Imam Santoso, S.H., No. 5 dated May 7, 1999.
Produk & Lini Bisnis
The Company’s scope of activities is engaged in healthcare services.
Dewan Direksi
H
Hasmoro
President Director
BP
Binsar Parasian Simorangkir
Director
YK
Yulisar Khiat
Director
AS
Aristo Sungkono Setiawidjaja
Independent Director
Dewan Komisaris
PK
Paulus Kusuma Gunawan
President Commissioner
HS
Husen Sutakaria
Vice President Commissioner
S
Sudarsono
Commissioner
DC
Darwin Cyrill Noerhadi
Commissioner
AS
Alexander Steven Rusli
Independent Commissioner
H
Heridadi
Independent Commissioner
AV
Amit Varma
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
%
Trend Keuangan (5 periode terakhir) β€” hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
7,1M 5,4M 3,6M 1,8M 0 Sales 2025Q2: Rp 3.388.561.000 Net Income 2025Q2: Rp 224.847.000 2025Q2 Sales 2025Q3: Rp 5.287.968.000 Net Income 2025Q3: Rp 356.017.000 2025Q3 Sales 2025Q4: Rp 7.133.538.000 Net Income 2025Q4: Rp 429.547.000 2025Q4 Sales 2026Q1: Rp 1.783.206.000 Net Income 2026Q1: Rp 101.262.000 2026Q1 Sales 2026Q2: Rp 3.609.409.000 Net Income 2026Q2: Rp 193.178.000 2026Q2
2025 Q2
EPS 29
ROE 8,22%
2025 Q3
EPS 31
ROE 8,47%
2025 Q4
EPS 28
ROE 7,57%
2026 Q1
EPS 26
ROE 7,08%
2026 Q2
EPS 25
ROE 7,01%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 3,61 T 193,18 M 11,99 T 5,51 T 25 7,01% 0.89x
2026 Q1 1,78 T 101,26 M 12,08 T 5,72 T 26 7,08% 0.84x
2025 Q4 7,13 T 429,55 M 11,89 T 5,68 T 28 7,57% 0.82x
2025 Q3 5,29 T 356,02 M 11,81 T 5,60 T 31 8,47% 0.83x
2025 Q2 3,39 T 224,85 M 11,92 T 5,47 T 29 8,22% 0.90x
Trend Harga Penutupan & Book Value β€” hover titik untuk detail
Close Price Book Value
1,8K 1,4K 1,1K 671 290 Book Value 2025Q2: Rp 356 Close 2025Q2: Rp 1.415 2025Q2 Book Value 2025Q3: Rp 365 Close 2025Q3: Rp 1.680 2025Q3 Book Value 2025Q4: Rp 369 Close 2025Q4: Rp 1.375 2025Q4 Book Value 2026Q1: Rp 372 Close 2026Q1: Rp 1.315 2026Q1 Book Value 2026Q2: Rp 359 Close 2026Q2: Rp 815 2026Q2
2025 Q2
Close 1.415
BV 356
ROA 3,77%
2025 Q3
Close 1.680
BV 365
ROA 4,02%
2025 Q4
Close 1.375
BV 369
ROA 3,61%
2026 Q1
Close 1.315
BV 372
ROA 3,35%
2026 Q2
Close 815
BV 359
ROA 3,22%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 815 359 3,22%
2026 1 1.315 372 3,35%
2025 4 1.375 369 3,61%
2025 3 1.680 365 4,02%
2025 2 1.415 356 3,77%
Data diperbarui pada: 2026-05-12 10:39:06